Mursla Bio announces promising results for EvoLiver test in liver cancer detection

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk patients through the power of dynamic biopsy technology, today announced results of its multi-center clinical study, MEV01, in collaboration with leading academic institutes including University College London, Imperial College London, University Hospital of Santa Maria and the Medical University of Graz.

AbbVie and Gilgamesh Commit to Innovative Psychiatric Solutions

The TDR Three Key Takeaways regarding AbbVie and Gilgamesh: Gilgamesh and AbbVie join forces to tackle innovative mental health therapies. Gilgamesh could earn up to

May 14, 2024

Big Pharma Enters The Psychedelic Space Beyond Partnerships Otsuka Acquires Mindset Pharma

Canadian next-generation psychedelics developer Mindset Pharma MSSTF has entered into a definitive agreement by which Otsuka America Inc., the U.S. arm of Otsuka Pharmaceutical Co., would acquire all its outstanding

August 31, 2023

In Maui, the Need for Medical Resources Continues

Though the toll of the wildfires in Maui remains to be completely seen, the need for medical and recovery resources continues. As of Thursday, the

August 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.